Crism Therapeutics (LSE:CRTX) Interest Expense : £-0.01 Mil (TTM As of Jun. 2024)

View and export this data going back to 2006. Start your Free Trial

What is Crism Therapeutics Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Crism Therapeutics's interest expense for the six months ended in Jun. 2024 was £ -0.01 Mil. Its interest expense for the trailing twelve months (TTM) ended in Jun. 2024 was £-0.01 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Crism Therapeutics's Operating Income for the six months ended in Jun. 2024 was £ -0.30 Mil. Crism Therapeutics's Interest Expense for the six months ended in Jun. 2024 was £ -0.01 Mil. Crism Therapeutics did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Crism Therapeutics Interest Expense Historical Data

The historical data trend for Crism Therapeutics's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Crism Therapeutics Interest Expense Chart

Crism Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-0.55

-0.01

Crism Therapeutics Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Interest Expense	Get a 7-Day Free Trial															-	-	-0.02	-	-0.01

Crism Therapeutics Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was £-0.01 Mil.

Crism Therapeutics (LSE:CRTX) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Crism Therapeutics's Interest Expense for the six months ended in Jun. 2024 was £-0.01 Mil. Its Operating Income for the six months ended in Jun. 2024 was £-0.30 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Jun. 2024 was £0.00 Mil.

Crism Therapeutics's Interest Coverage for the quarter that ended in Jun. 2024 is calculated as

Crism Therapeutics did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Crism Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Crism Therapeutics Corp (LSE:CRTX) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Kingston Chambers, P.O. Box 173, Tortola, Road Town, VGB

Website

https://www.crismtherapeutics.com

Crism Therapeutics Corp has developed a drug delivery technology to improve the clinical performance of cancer treatments for solid tumours through the local delivery of chemotherapy drugs. Its product ChemoSeed which is in its clinical trial phase, can be implanted directly into the tumour or the resection margin following the removal of a tumour. The company also provides consultancy and formulation services to its clients assisting them with pharmaceutical formulation and development.

Crism Therapeutics Headlines

No Headlines